Prescient Therapeutics: PTX-100 Phase 2 coming soon
Prescient Therapeutics update report 2024 08 29
Prescient Therapeutics update report 2024 08 29
ASX-listed oncology drug developer Prescient Therapeutics (ASX:PTX) is set for major milestones in the months...
Prescient Therapeutics is a Melbourne-based drug developer focused on cancer, with several platforms and products...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.